What is mild cognitive impairment?
Mild cognitive impairment (MCI) happens when you experience a slight — but noticeable — decline in mental abilities compared to others
your age. Mental abilities include:
Memory.
Reasoning and judgment.
Planning and completing complex tasks.
You may notice the decline in your abilities, or a loved one might. But the changes aren’t severe enough to interfere with daily, routine activities of life.
What’s the difference between mild cognitive impairment and mental decline due to aging?
It’s natural and expected to have some gradual mental decline as you age. For example, learning new information may take longer than before. Or your speed of performance may get slower.
But these declines due to aging don’t affect your overall functioning or ability to perform daily activities. Normal aging doesn’t affect recognition, intelligence or long-term memory.
As you age beyond 55 years, you may occasionally forget names and words and misplace things. With mild cognitive impairment, you frequently forget conversations and information that you would typically remember, like appointments and other planned events. MCI interferes with your daily, routine activities.
What’s the difference between dementia and mild cognitive impairment?
Both dementia and MCI are descriptive terms that tell us about the degree of cognitive change and how it affects daily activities. The main difference between MCI and dementia is that the mental decline in MCI doesn’t interfere with daily living, whereas dementia does. In addition, people with MCI don’t experience personality changes that people with dementia can. Many underlying conditions can lead to MCI or dementia.
Dementia involves a decline in mental function from a previously higher level that’s severe enough to interfere with daily living.
A person with dementia has two or more of these specific difficulties, including a decline in:
Memory, Reasoning, Language, Coordination, Mood, Behavior.
How common is mild cognitive impairment?
The American Academy of Neurology estimates that mild cognitive impairment is present in the following populations:
8% of people aged 65 to 69.
15% of people aged 75 to 79.
25% of people aged 80 to 84.
37% of people 85 or older.
You may notice the decline in your abilities, or a loved one might. But the changes aren’t severe enough to interfere with daily, routine activities of life.
What causes mild cognitive impairment?
Mild cognitive impairment can have several possible causes. Some are treatable and others aren’t.
Some of the possible causes include:
Depression, chronic stress and anxiety, Thyroid, kidney or liver problems.Sleep apnea and other sleep disorders.
Conditions that affect blood flow in your brain, like tumors, blood clots, stroke or traumatic brain injury.Vitamin B12 deficiency or other nutrient deficiencies.
Side effects of certain prescription medications, like calcium channel blockers, anticholinergic drugs, benzodiazepines and others.
Substance use disorder and alcohol use disorder.
MCI is often an early stage of certain neurodegenerative conditions. MCI can be an early stage of:
Alzheimer’s disease.
Parkinson’s disease.
Lewy body dementia.
Vascular dementia.
Frontotemporal dementia.
What are the risk factors for mild cognitive impairment?
The strongest risk factors for mild cognitive impairment are the same as those for dementia:
Being 65 or older.
Having a biological family history of dementia.
Having conditions that increase your risk of cardiovascular disease, including high blood pressure, high cholesterol levels, diabetes and obesity.
Neuroprotective and Antioxidant Effect of Ginkgo biloba ...
National Institutes of Health (NIH) (.gov)
https://pubmed.ncbi.nlm.nih.gov
by SK Singh • 2019 • Cited by 282 — Among the herbal extract, Ginkgo biloba extract (GBE) is one of the most investigated herbal remedy for cognitive disorders and Alzheimer's……….
Current Perspectives on the Beneficial Role of Ginkgo Biloba
National Institutes of Health (NIH) (.gov)
https://pubmed.ncbi.nlm.nih.gov
by KM Nash • 2015 • Cited by 129 — Recent studies show anxiolytic properties of ginkgolide A, migraine with aura treatment by ginkgolide B, a reduction in ischemia-induced ...
Ginkgo biloba extract improved cognitive and neurological disorders
Stroke and Vascular Neurology
https://svn.bmj.com › content
by S Li • 2017 • Cited by 64 — Ginkgo biloba extract improved cognitive and neurological functions of acute ischemic stroke: a randomized controlled trial | Stroke and Vascular
Current Perspectives on the Beneficial Role of Ginkgo biloba ...
Sage Journals
https://journals.sagepub.com › doi › IMI.S25054
Recent studies show anxiolytic properties of ginkgolideA, migraine with aura treatment by ginkgolide B, a reduction in ischemia-induced glutamate
The Efficacy of Ginkgo biloba on Cognitive Function
JAMA
https://jamanetwork.com › jamaneurology › fullarticle
by BS Oken • 1998 • Cited by 827 — Clinically, ginkgo extract is widely used in Europe for treatment of memory disorders associated with aging, including AD and vascular dementia.
Protective Role of Capsaicin in Neurological Disorders
National Institutes of Health (NIH)
https://pubmed.ncbi.nlm.nih.gov
by S Tyagi • 2022 • Cited by 15 — Several studies have shown the neuroprotective role of capsaicin against oxidative damage, behavioral impairment, with 6-hydroxydopamine
Protective Role of Capsaicin in Neurological Disorders
Springer
https://link.springer.com › Neurochemical Research
protective role of capsaicin in neurological disorders from link.springer.com
by S Tyagi • 2022 • Cited by 15 — Several studies have shown the neuroprotective role of capsaicin against oxidative damage, behavioral impairment, with 6-hydroxydopamine (6-OHDA) ...
Capsaicin: A Potential Treatment to Improve Cognition
MDPI
https://www.mdpi.com
by T Thornton • 2023 • Cited by 9 — Due to this, capsaicin attenuates the progression of neurological disorders, such as dementia in animals. ... Protective role of capsaicin in
Effect of capsaicin on the oxidative stress and dopamine
CORE
https://core.ac.uk › download › pdf
by YH SIDDIQUE • 2018 • Cited by 21 —
The results suggest the protective role of capsaicin against the PD symptoms. Keywords: Capsaicin – Parkinson's disease – reactive
Protective Effect of Antioxidants on Neuronal Dysfunction
National Institutes of Health (NIH) (.gov)
https://www.ncbi.nlm.nih.gov › articles › PMC5266860
by T Velusamy • 2017 • Cited by 53 — The supportive role of antioxidants to reduce the severity of HD via promoting the functional neurogenesis and neuroprotection in the
Antioxidant Therapy in Neurologic Disease
JAMA
https://jamanetwork.com › jamaneurology › fullarticle
by N Delanty • 2000 • Cited by 220 — Therapy using free radical scavengers (antioxidants) has the potential to prevent, delay, or ameliorate many neurologic disorders.
Neuroprotective Effect of Antioxidants in the Brain
MDPI
https://www.mdpi.com › ...
Protective role of ANTIOXIDANTS in neurological disorders from www.mdpi.com
by KH Lee • 2020 • Cited by 285 — The brain is vulnerable to excessive oxidative insults because of its abundant lipid content, high energy requirements, and weak antioxidant capacity.